Kevin van Dooren

Vice President HEOR & Market Access, Propharma group

Kevin van Dooren holds the position of Vice President, Health Economics and Outcomes Research (HEOR) and Market Access Kevin brings more than 15 years of experience in health economics, market access, reimbursement, and HTA strategy, with a strong track record of enabling access for innovative therapies across pharmaceuticals, MedTech, and digital health. His expertise spans global and affiliate roles, providing a unique ability to connect strategic market access planning with practical, in-market execution.

Events Kevin van Dooren has spoken at

World EPA Congress Europe 2027 2 March 2027 – 3 March 2027